Abbott has agreed to acquire Exact Sciences, a cancer screening and diagnostics tests provider, for a total equity value of approximately $21 billion. The transaction, announced Nov. 20, is expected ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback